Literature DB >> 10999237

Respiratory sinus arrhythmia biofeedback therapy for asthma: a report of 20 unmedicated pediatric cases using the Smetankin method.

P Lehrer1, A Smetankin, T Potapova.   

Abstract

This multiple case study describes pulmonary function changes in 20 asthmatic children from 30 consecutive cases undergoing biofeedback training for increasing the amplitude of respiratory sinus arrhythmia (RSA). The Smetankin protocol was used, which, in addition to RSA biofeedback, includes instructions in relaxed abdominal pursed-lips breathing. Ten individuals were excluded, including 6 who had been taking asthma medication, 2 who developed viral infections during the treatment period, and 2 who dropped out prior to completing treatment. Patients each received 13 to 15 sessions of training. Asthma tended to be mild, with mean spirometric values close to normal levels. Nevertheless, significant improvements were noted in 2 spirometry measures taken during forced expiratory maneuvers from maximum vital capacity: FEV1 and FEF50. These preliminary uncontrolled data suggest that the Smetankin protocol warrants further evaluation as a nonpharmacological psychophysiological treatment for this condition, although these data could not definitively prove that the method is effective.

Entities:  

Mesh:

Year:  2000        PMID: 10999237     DOI: 10.1023/a:1009506909815

Source DB:  PubMed          Journal:  Appl Psychophysiol Biofeedback        ISSN: 1090-0586


  10 in total

1.  A computational physiology approach to personalized treatment models: the beneficial effects of slow breathing on the human cardiovascular system.

Authors:  Maria Fonoberova; Igor Mezić; Jennifer F Buckman; Vladimir A Fonoberov; Adriana Mezić; Evgeny G Vaschillo; Eun-Young Mun; Bronya Vaschillo; Marsha E Bates
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-25       Impact factor: 4.733

2.  Heart rate variability biofeedback: Theoretical basis, delivery, and its potential for the treatment of substance use disorders.

Authors:  David Eddie; Evgeny Vaschillo; Bronya Vaschillo; Paul Lehrer
Journal:  Addict Res Theory       Date:  2015-02-17

3.  SUBSTANCE USE AND ADDICTION AFFECT MORE THAN THE BRAIN: THE PROMISE OF NEUROCARDIAC INTERVENTIONS.

Authors:  David Eddie; Julianne L Price; Marsha E Bates; Jennifer Buckman
Journal:  Curr Addict Rep       Date:  2021-08-09

Review 4.  Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine.

Authors:  Afton L Hassett; Richard N Gevirtz
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

5.  A multilevel prediction of physiological response to challenge: Interactions among child maltreatment, neighborhood crime, endothelial nitric oxide synthase gene (eNOS), and GABA(A) receptor subunit alpha-6 gene (GABRA6).

Authors:  Michael Lynch; Jody Todd Manly; Dante Cicchetti
Journal:  Dev Psychopathol       Date:  2015-11

Review 6.  My Life in HRV Biofeedback Research.

Authors:  Paul Lehrer
Journal:  Appl Psychophysiol Biofeedback       Date:  2022-03-07

7.  Coherence: a novel nonpharmacological modality for lowering blood pressure in hypertensive patients.

Authors:  Abdullah A Alabdulgader
Journal:  Glob Adv Health Med       Date:  2012-05

8.  Non-pharmacological Intervention for Chronic Pain in Veterans: A Pilot Study of Heart Rate Variability Biofeedback.

Authors:  Melanie E Berry; Iva T Chapple; Jay P Ginsberg; Kurt J Gleichauf; Jeff A Meyer; Madan L Nagpal
Journal:  Glob Adv Health Med       Date:  2014-03

9.  Resilience Training Program Reduces Physiological and Psychological Stress in Police Officers.

Authors:  Rollin McCraty; Mike Atkinson
Journal:  Glob Adv Health Med       Date:  2012-11-01

10.  Evaluation of Myoelectric Activity of Paraspinal Muscles in Adolescents with Idiopathic Scoliosis during Habitual Standing and Sitting.

Authors:  Garcia Kwok; Joanne Yip; Mei-Chun Cheung; Kit-Lun Yick
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.